Form 8-K - Current report:
SEC Accession No. 0001628280-22-028761
Filing Date
2022-11-08
Accepted
2022-11-08 07:56:42
Documents
14
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bvs-20221108.htm   iXBRL 8-K 42475
2 EX-99.1 bioventusex-991q32022.htm EX-99.1 468456
6 image_0a.jpg GRAPHIC 50612
  Complete submission text file 0001628280-22-028761.txt   761246

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bvs-20221108.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bvs-20221108_lab.xml EX-101.LAB 25848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bvs-20221108_pre.xml EX-101.PRE 13582
8 EXTRACTED XBRL INSTANCE DOCUMENT bvs-20221108_htm.xml XML 12369
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 221367297
SIC: 3841 Surgical & Medical Instruments & Apparatus